Maritn is memebr of the Jewell lab.
UMD bioengineers aim to shape the future of cancer vaccine technology by tuning the body’s immune response.
Prof. Chris Jewell and his lab are investigating how the biophysical properties of nanomaterials used in immunotherapies shape treatment outcomes.
Findings show that a novel immunotherapy strategy might one day be used to treat multiple sclerosis patients without leaving them immunocompromised.
